State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT05949580 N/A
Recruiting
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Med...
Condition
Relapsing Remitting Multiple Sclerosis
Enrollment
500 pts
Location
United States, Germany
Sponsor
Hoffmann-La Roche
NCT05863195 Phase 3
Recruiting
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus St...
Condition
Metastatic Colorectal Carcinoma
Enrollment
408 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT07008781 N/A
Recruiting
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer Screening
Condition
Cancer
Enrollment
84 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metast...
Condition
Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
NCT07454330 N/A
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Su...
Condition
Cancer
Enrollment
64 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05985161 Phase 2
Recruiting
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
Condition
Wilms Tumor
Enrollment
45 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT05156983 Phase 3
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Nee...
Condition
Coagulation Disorder
Enrollment
328 pts
Location
United States, Argentina, Austria
Sponsor
Takeda
NCT05239624 Phase 2
Recruiting
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
Condition
Urothelial Carcinoma
Enrollment
23 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06728579 Phase 2
Recruiting
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joi...
Condition
Breast Cancer Survivor
Enrollment
200 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT04989803 Phase 1, Phase 2
Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-...
Condition
Relapsed and/or Refractory B-cell Lymphoma
Enrollment
247 pts
Location
United States, Australia, Germany
Sponsor
Kite, A Gilead Company
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07212166 N/A
Recruiting
A Study of Questionnaires in Adolescents and Young Adults With Cancer
Condition
Adolescents and Young Adults With Cancer
Enrollment
120 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT01429389 N/A
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Condition
Down Syndrome
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Sequenom, Inc.
NCT05787379 N/A
Recruiting
Care for Veterans Post-COVID-19
Condition
Post-Acute COVID-19 Syndrome
Enrollment
348 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT07288320 Phase 2
Recruiting
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults...
Condition
Bipolar I Disorder
Enrollment
150 pts
Location
United States
Sponsor
Neurocrine Biosciences
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT02555280 N/A
Recruiting
Coflex PS3 Actual Conditions for Use Study
Condition
Spinal Stenosis Lumbar
Enrollment
300 pts
Location
United States
Sponsor
Xtant Medical
NCT07221474 Phase 2
Recruiting
A Study of V940/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous ...
Condition
Squamous Non-small Cell Lung Cancer
Enrollment
180 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06133920 N/A
Recruiting
Duration of Immobilization After Reverse Total Arthroplasty for Proximal Humerus...
Condition
Proximal Humeral Fracture
Enrollment
40 pts
Location
United States
Sponsor
The Cooper Health System
NCT06745479 N/A
Recruiting
Decision-Making in Schizophrenia: A Combined Neuroimaging and Experience Samplin...
Condition
Schizophrenia
Enrollment
74 pts
Location
United States
Sponsor
Rutgers, The State University